Furthermore, research has indicated that primary melanoma lesions and melanocytic nevi have high expression of LGALS9, but the minimal expression is found in metastatic melanoma lesions due to the tumor-suppressor function of LGALS9, which inhibits metastatic progression (40, 41). The gene discussed is LGALS9; the disease is neoplasm.